Cell adhesion molecules: potential therapeutic and diagnostic implications.
Mousa
Shaker A
SA
Albany College of Pharmacy, NY, USA.
D000818:Animals; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D002448:Cell Adhesion; D015815:Cell Adhesion Molecules / Q000032:analysis / Q000037:antagonists & inhibitors / Q000502:physiology*; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000517:prevention & control; D016326:Extracellular Matrix Proteins / Q000502:physiology; D006801:Humans; D016023:Integrins / Q000037:antagonists & inhibitors / Q000502:physiology; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D019087:Selectins / Q000502:physiology; D015398:Signal Transduction
D015815:Cell Adhesion Molecules; D016326:Extracellular Matrix Proteins; D016023:Integrins; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D019087:Selectins